Location: Home
  • search
  • go
  • Relate News
  • 3/28/2025NiKang Thera Completes Dosing of the First Cohort in a Phase 1 Study ...
  • 3/28/2025TaiMed Announces Results from Phase 2a Data on Long-Acting HIV Mainten...
  • 3/28/2025Recent Executive Moves
  • 3/28/2025China Releases Draft Implementation Measures for the Protection of Dru...
  • 3/27/2025Big Pharma Faces Headwinds in China as Vaccine Sales Decline (PT)
  • 3/27/2025China to Spur Innovation through New Reimbursement List (ThePharmaLett...
  • 3/27/2025China Poised to Surpass Europe in Pharma Innovation, Says AZ CEO
  • 3/27/2025China Faces Ongoing TB Prevention Challenges Despite Declining Inciden...
  • 3/27/2025NMPA Approves Suraxavir Marboxil for Influenza Treatment
  • 3/26/2025Merck Licenses Hengrui's Investigational Lp(a) Inhibitor HRS-5346
  • 3/26/2025Ractigen's RAG-01 Shows Promising Early Complete Responses in Phase I ...
  • 3/26/2025NMPA Holds 2025 National Drug Regulatory Policy and Law Conference
  • 3/26/2025NMPA Issues Announcement on the Implementation of Chinese Pharmacopoei...
  • 3/26/2025Bayer Secures Global Rights to Puhe BioPharma's Experimental Cancer Dr...
  • 3/26/2025Life Science Ecosystems in Asia: Biomedical Innovation Trends over the...
  • 3/25/2025Anda Biopharma Secures Series A Funding to Advance PCNAT-01 Clinical S...
  • 3/25/2025Novo Nordisk and the United Labs Announce License Deal for UBT251
  • 3/25/2025BrightGene Initiates Phase II Head-to-Head Study of AI-Designed BGM050...
  • 3/25/2025Everest Announces FDA Clearance of IND Application for Tumor-Associate...
  • 3/25/2025Eli Lilly Launches Lilly Gateway Laboratory in Beijing to Foster Innov...
  • 3/25/2025Merck Group to Expand in China with Focus on AI-Powered Precision Medi...
  • 3/25/2025China's BMI Fund Surpasses CNY16.5 Trillion with 11% Annual Growth
  • 3/25/2025Expedition Therapeutics Secures Seed Funding to Bridge Chinese Innovat...
  • 3/25/2025Growing Awareness and Expanding Treatment Options for Sleep Disorders ...
  • 3/25/2025Hengrui and Elevar Face Second FDA Rejection for Liver Cancer Combo Th...
  • 3/24/2025Elevation Oncology to Discontinue Development of CSPC-licensed EO-3021
  • 3/24/2025HBM Enters into Global Strategic Deal with AstraZeneca for Next-Gen Th...
  • 3/24/2025AstraZeneca Announces $2.5B Investment in China
  • 3/24/2025Syneron Bio Announces Strategic Collaboration with AstraZeneca
  • 3/24/2025GenScript's RA Drug Candidate Receives FDA Clearance for Clinical Tria...
  • Page:40/797 Total number of articles:23898: [First][<<] [38] [39] [40] [41] [42] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group